Baxter International (BAX) Research & Development (2016 - 2024)
Historic Research & Development for Baxter International (BAX) over the last 16 years, with Q1 2024 value amounting to $176.0 million.
- Baxter International's Research & Development rose 731.71% to $176.0 million in Q1 2024 from the same period last year, while for Mar 2024 it was $530.0 million, marking a year-over-year increase of 1397.85%. This contributed to the annual value of $590.0 million for FY2024, which is 1389.96% up from last year.
- As of Q1 2024, Baxter International's Research & Development stood at $176.0 million, which was up 731.71% from $23.0 million recorded in Q4 2023.
- Over the past 5 years, Baxter International's Research & Development peaked at $176.0 million during Q1 2024, and registered a low of $2.0 million during Q4 2022.
- In the last 5 years, Baxter International's Research & Development had a median value of $139.0 million in 2021 and averaged $129.2 million.
- In the last 5 years, Baxter International's Research & Development plummeted by 9851.85% in 2022 and then soared by 105000.0% in 2023.
- Baxter International's Research & Development (Quarter) stood at $135.0 million in 2020, then changed by 0.0% to $135.0 million in 2021, then crashed by 98.52% to $2.0 million in 2022, then surged by 1050.0% to $23.0 million in 2023, then surged by 665.22% to $176.0 million in 2024.
- Its last three reported values are $176.0 million in Q1 2024, $23.0 million for Q4 2023, and $166.0 million during Q3 2023.